Furthermore, the therapeutic effect of the WBT formula on IPF was most likely achieved through modulating multiple pathways such as the PI3K-Akt, TNF, and NF-κB pathways. This evidence concerns the gene AKT1 and idiopathic pulmonary fibrosis.